VJRegenMed is committed to improving our service to you

Share this video  

VJRegenMed is committed to improving our service to you

Meeting on the Med 2022 | The future of omentum-based autologous tissue engineering

Advances in autologous tissue regeneration in the form of an omentum-derived hydrogel and induced pluripotent stem cell (iPSC)-derived tissue have led to promising therapies for spinal cord injury and cardiac infarction. Asaf Toker, MD, Matricelf, Ness Ziona, Israel, provides an overview of the future of this novel technology. Whilst currently only being assessed in two indications, this method of autologous tissue engineering can theoretically be applied to any type of damaged tissue. Potential indications include Parkinson’s Disease, age-related macular degeneration (AMD) and other musculoskeletal disorders. This interview was conducted during Meeting on the Mediterranean 2022.